Kabir ’s Bakery issues allergy alert on undeclared milk in “Kabir’s Bakery Cinnamon Twist” and “Kabir’s Bakery Cinnamon Raisin Danish” in four ounce plastic packages, all container codes.

Kabir ’s Bakery of Brooklyn, NY is recalling “Kabir’s Bakery Cinnamon Twist“ and “Kabir’s Bakery Cinnamon Raisin Danish” in four ounce plastic packages, all container codes, due to the presence of undeclared milk. Consumers who are allergic to milk run the risk of serious life threatening a llergic reactions if they consume this product
Source: Food and Drug Administration - Category: Food Science Source Type: news

Related Links:

AbbVie Inc. said it's buying Dublin, Ireland-based drug firm Allergan in a $63 billion deal. AbbVie (NYSE: ABBV), based in North Chicago, Illinois, said it's paying 0.8660 of its shares and $120.30 in cash for each Allergan (NYSE: AGN) share, for a total consideration of $188.24 per Allergan share. AbbVie said the combined companies' headquarters will remain in North Chicago. "This is a transformational transaction for both companies and achieves unique and complementary strategic objectives.…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Publication date: September 2019Source: Phytochemistry, Volume 165Author(s): Takahiro Okada, Hideyuki Ihara, Yoshitaka IkedaAbstractIn higher plants, asparagine-linked oligosaccharides (N-glycans) in glycoproteins carry unique carbohydrate epitopes, namely, a core α1,3-fucose and/or a β1,2-xylose, which are common determinants responsible for the cross-reactivity of plant glycoproteins due to their strong immunogenicity. While these determinants and the relevant genes have been well characterized for herbaceous plants, information concerning whether many food plants cross-react with airborne pollens is not avail...
Source: Phytochemistry - Category: Chemistry Source Type: research
Conditions:   Pneumonia, Bacterial;   Viral Infection;   Clinical Pneumonia;   Plasmodium Falciparum Malaria;   Malaria;   Infections, Respiratory Intervention:   Sponsors:   Boston University;   National Institute of Allergy and Infectious Diseases (NIAID);   Medical Research Council Unit, The Gambia, LSTMH;   Laboratory of Transnational Immunology, UMC Utrecht Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Latest drug industry megamerger comes as AbbVie faces patent expiration for Humira
Source: Chemical and Engineering News - Category: Chemistry Authors: Source Type: research
The acquisition aims to diversify AbbVie beyond its top-selling drug Humira, which will soon lose patent protection
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
AbbVie Inc. said it's buying Dublin, Ireland-based drug firm Allergan in a $63 billion deal. AbbVie (NYSE: ABBV), based in North Chicago, Illinois, said it's paying 0.8660 of its shares and $120.30 in cash for each Allergan (NYSE: AGN) share, for a total consideration of $188.24 per Allergan share. AbbVie said the combined companies' headquarters will remain in North Chicago. "This is a transformational transaction for both companies and achieves unique and complementary strategic objectives.…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
AbbVie Inc. said it's buying Dublin, Ireland-based drug firm Allergan in a $63 billion deal. AbbVie (NYSE: ABBV), based in North Chicago, Illinois, said it's paying 0.8660 of its shares and $120.30 in cash for each Allergan (NYSE: AGN) share, for a total consideration of $188.24 per Allergan share. AbbVie said the combined companies' headquarters will remain in North Chicago. "This is a transformational transaction for both companies and achieves unique and complementary strategic objectives.…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
Cash and stock offer marks latest blockbuster deal in healthcare sector
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
Provides immediate scale and profitability to AbbVie's growth platform, excluding Humira, significantly expanding and diversifying its revenue base with new therapeutic areas, including Allergan's leading medical aesthetics business Enhances long-term R... Biopharmaceuticals, Mergers &Acquisitions AbbVie, Allergan
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
Publication date: Available online 6 June 2019Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Timothy J. Watts, David Thursfield, Rubaiyat Haque
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
More News: Allergy | Allergy & Immunology | Cinnamon | Food and Drug Administration (FDA) | Food Science | Raisins